These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
508 related articles for article (PubMed ID: 4388895)
1. [Pharmacological properties of the new neuroleptic of the phenothiazine series--dixyrazine]. Mikhaĭlova TV; Terekhina AI; Gilev AP Farmakol Toksikol; 1969; 32(1):28-31. PubMed ID: 4388895 [No Abstract] [Full Text] [Related]
2. [Experimental study of the pharmacological effect of oxyphenamate]. Gorshkova VK; Mikhaĭlova TV; Gilev AP Farmakol Toksikol; 1970; 33(3):264-7. PubMed ID: 5465696 [No Abstract] [Full Text] [Related]
3. [On the potentiation of the tranquilizing properties of aminazine by novocaine]. Izgina NZ Farmakol Toksikol; 1968; 31(2):142-5. PubMed ID: 5674662 [No Abstract] [Full Text] [Related]
4. [Characteristics of spectrum of pharmacological activity of hyndarine (1-tetrahydropalmatine) and its effect on the metaboli of catecholamines]. Berezhinskaia VV; Trutneva EA Farmakol Toksikol; 1966; 29(6):731-4. PubMed ID: 6000372 [No Abstract] [Full Text] [Related]
10. Pharmacological studies on 5-(3-(4-piperidino-4-carbamoyl-piperidino)-propyl)-10,11-dihydro-5(H)-dibenz-(b,f)-azepine (carpipramine) dihydrochloride, a new psychotropic agent. Nakanishi M; Tsumagari T; Okada T; Kasé Y Arzneimittelforschung; 1968 Nov; 18(11):1435-41. PubMed ID: 5755909 [No Abstract] [Full Text] [Related]
11. Pimozide, a chemically novel, highly potent and orally long-acting neuroleptic drug. I. The comparative pharmacology of pimozide, haloperidol, and chlorpromazine. Janssen PA; Niemegeers CJ; Schellekens KH; Dresse A; Lenaerts FM; Pinchard A; Schaper WK; van Nueten JM; Verbruggen FJ Arzneimittelforschung; 1968 Mar; 18(3):261-79. PubMed ID: 4386815 [No Abstract] [Full Text] [Related]
12. Pharmacological study of 2-ethyl-4-ethylamino-6-methoxy-s-triazine, a new compound with both central sympathetic and parasympathetic stimulating properties. Chiba S; Saji Y; Hibino H; Takeo Y; Yui T Arzneimittelforschung; 1968 Mar; 18(3):303-9. PubMed ID: 4386816 [No Abstract] [Full Text] [Related]
13. Pharmacological properties of substituted gamma-butyrolactones. I. The effects on the central nervous system. Sieroslawska J; Hano J; Sypniewska M; Czarnecki R; Chojnacka-Wójcik E; Harasiewicz A Pol J Pharmacol Pharm; 1973; 25(1):1-16. PubMed ID: 4798097 [No Abstract] [Full Text] [Related]
15. Pharmacological study of 1-(beta-phenylethyl) triazolo (4,5-c) pyridine hydrochloride, a tranquillizing agent. Ahmad A; Vohra MM; Achari G Jpn J Pharmacol; 1967 Dec; 17(4):622-30. PubMed ID: 5301352 [No Abstract] [Full Text] [Related]
16. [On the pharmacology of 2,3-dioxybenzoic acid]. Polukordas G; Repchite M; Skublitskene G Farmakol Toksikol; 1966; 29(5):594-7. PubMed ID: 5995071 [No Abstract] [Full Text] [Related]
17. [Pharmacological, pharmacokinetic and toxicological research on mesoridazine (NC 123)]. Loew DM; Grauwiler J; Griffith R; Taeschler M; Weidmann H; Zehnder K Boll Chim Farm; 1967 May; 106(5):332-71. PubMed ID: 4890002 [No Abstract] [Full Text] [Related]
18. Neuroleptic phenothiazines with 1,4-diazabicyclo-[4.4.0]decane and-[4.3.0]nonane Ring System. Casagrande C; Galli A; Ferrini R; Miragoli G Arzneimittelforschung; 1971 Jun; 21(6):808-11. PubMed ID: 4104913 [No Abstract] [Full Text] [Related]
19. [Prosopinine, an alkaloid from Prosopis africana (Legumineous). Its effects on the central and autonomic nervous systems]. Bourrinet P; Quevauviller A C R Seances Soc Biol Fil; 1968; 162(5):1138-40. PubMed ID: 4236219 [No Abstract] [Full Text] [Related]